Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Lees

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Stroke|March 1, 1995
Clinical experience with excitatory amino acid antagonist drugsK W Muir, K R Lees
British Medical Journal (Clinical Research Ed.)|February 7, 1987
Treatment of cardiovascular diseasesK R Lees, P C Rubin
Cerebrovascular Diseases (Basel, Switzerland)|April 4, 2009
Hyperglycaemia in acute stroke--to treat or not to treatT J Quinn, K R Lees
BMJ (Clinical Research Ed.)|March 31, 2000
ABC of arterial and venous disease. Acute strokeP M Bath, K R Lees
Stroke|May 7, 1999
Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute strokeA G Dyker, K R Lees
Clinical Pharmacology and Therapeutics|June 1, 1987
Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatmentK R Lees, J L Reid
British Journal of Clinical Pharmacology|February 1, 1987
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in manK R Lees, J L Reid
European Journal of Clinical Pharmacology|January 1, 1987
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patientsK R Lees, J L Reid
Journal of Cardiovascular Pharmacology|August 1, 1987
Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjectsK R Lees, J L Reid
Scottish Medical Journal|August 17, 2006
21st century stroke--A medical emergencyJ Dawson, M Walters, K R Lees
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Stroke|March 1, 1995
Clinical experience with excitatory amino acid antagonist drugsK W Muir, K R Lees
British Medical Journal (Clinical Research Ed.)|February 7, 1987
Treatment of cardiovascular diseasesK R Lees, P C Rubin
Cerebrovascular Diseases (Basel, Switzerland)|April 4, 2009
Hyperglycaemia in acute stroke--to treat or not to treatT J Quinn, K R Lees
BMJ (Clinical Research Ed.)|March 31, 2000
ABC of arterial and venous disease. Acute strokeP M Bath, K R Lees
Stroke|May 7, 1999
Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute strokeA G Dyker, K R Lees
Clinical Pharmacology and Therapeutics|June 1, 1987
Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatmentK R Lees, J L Reid
British Journal of Clinical Pharmacology|February 1, 1987
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in manK R Lees, J L Reid
European Journal of Clinical Pharmacology|January 1, 1987
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patientsK R Lees, J L Reid
Journal of Cardiovascular Pharmacology|August 1, 1987
Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjectsK R Lees, J L Reid
Scottish Medical Journal|August 17, 2006
21st century stroke--A medical emergencyJ Dawson, M Walters, K R Lees
Pageof 20